BioWorld Science

Oct. 17, 2007

View Archived Issues

Motavizumab safe in children treated for a second respiratory syncytial virus season

Read More

Diindolylmethane a possible alternative to surgery for cervical dysplasia

Read More

Increased CSF levels of NGF and BDNF detected in patients with migraine or PFMS

Read More

Rights to civamide acquired by OPKO Health

Read More

NIAID expands Imvamune smallpox vaccine trials in persons with atopic dermatitis

Read More

Ariad and Icon codevelop deforolimus-eluding stents

Read More

Maas Biolab awarded NIH grant to develop intrathecal ciclosporin

Read More

Amarillo Biosciences issues update on clinical trials

Read More

Novel agents for musculoskeletal and connective tissue disorders disclosed in recent patents

Read More

Alpharma to license U.S. rights for topical NSAID pain drug

Read More

Covidien and BioSynthema sign agreement for nuclear medicine cancer therapy

Read More

Results for BDM-E phase I/II clinical trial

Read More

Positive phase IIa clinical study results for MN-221 in status asthmaticus

Read More

Hisamitsu reports results of phase III HFT-290 trial

Read More

Nile reports positive phase I results for CD-NP in heart failure

Read More

Masitinib mesylate safe and effective in indolent systemic mastocytosis

Read More

Preclinical safety study of GSAO, a potential anticancer compound

Read More

Pozen responds to FDA approvable letter for Trexima

Read More

The FDA extends regulatory review period for Tysabri for Crohn's disease

Read More

Hycamtin approved for treatment of relapsed small cell lung cancer

Read More

Partial hold on clinical development of Telcyta removed

Read More

FDA approves Ixempra for the treatment of advanced breast cancer

Read More

Recent AstraZeneca patent describes novel therapeutic agents for respiratory disorders

Read More

New agents for treating HIV infection reported in recent Trimeris patent

Read More